Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 28 2025
0mins
Source: Newsfilter
Voluntary Delisting Announcement: Enzo Biochem, Inc. has announced its intention to voluntarily delist its common stock from the NYSE due to non-compliance with listing standards and will transition to trading on the OTCQX Best Market, effective around April 18, 2025.
Company Background: Enzo Biochem has been a life sciences company for over 45 years, focusing on various technologies and products in areas such as cell biology and genomics, while continuing to meet reporting requirements post-delisting.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
